NCM
ZLAB icon

Nantahala Capital Management’s Zai Lab ZLAB Stock Holding History

Nantahala Capital Management’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.8M Buy
+200,000
New +$3.95M 0.13% 116

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Nantahala Capital Management's ZLAB Position: Q2 2026 in Review

Nantahala Capital Management opened a new position in Zai Lab (ZLAB) in Q2 2026: 200,000 shares worth $3.8M. The stake represents 0.13% of the portfolio and ranks #116 among its holdings.

93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • Nantahala Capital Management held 200,000 shares of Zai Lab worth $3.8M as of Q2 2026.
  • Zai Lab was a new Nantahala Capital Management position in Q2 2026.
  • Zai Lab made up 0.13% of Nantahala Capital Management's portfolio in Q2 2026, its #116 holding.
  • 93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.